Epigenetic marker partially mediates the association between statin therapy and type 2 diabetes risk

11 April 2019 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Ms Carolina Ochoa-Rosales

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail

Urinary ethyl glucuronide as measure of alcohol consumption and cardiovascular disease: a population-based cohort study

Ms I. van de Luitgaarden (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Body mass index and blood pressure as predictors of cardiomegaly-associated line-of-duty sudden cardiac death in US firefighters: a case-control study

Doctor M. Korre (Boston, US)

Abstract Slides Video

Presentation thumbnail

Greater cardiorespiratory fitness reduces atrial fibrillation incidence: a meta-analysis

Mr C. Verdicchio (Canberra, AU)

Presentation thumbnail

Arterial age and early vascular aging, but not chronological age, are associated with faster thoracic aortic aneurysm growth

Doctor N. Santi (Ottawa, CA)

Abstract Slides Video

Presentation thumbnail

Beta-blocker after acute coronary syndrome: is it time to individualize therapy?

Doctor P. Azevedo (Faro, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Young Investigator Award 1 - Population science and public health Section

The Event

EuroPrevent 2019

11 April - 13 April 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Medical treatment works! Contemporary implementation into clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources